Ultragenyx Pharmaceutical | Costo Del Venduto



Cost Of Sales Cambiamento Data
Acadia Pharmaceuticals USD 21.8M 2.95M 2024-12
Agios Pharmaceuticals USD 1.08M 175K 2025-03
Alnylam Pharmaceuticals USD 71.04M 31.78M 2025-03
BioMarin Pharmaceutical USD 151.56M 15.42M 2025-03
Insmed USD 26.15M 4.98M 2024-12
Ionis Pharmaceuticals USD 1000K 2.83M 2025-03
Kyowa Hakko Kirin JPY 24.59B 9.95B 2025-03
MacroGenics USD 5.49M 3.62M 2024-12
Moderna USD 90M 456M 2025-03
Neurocrine Biosciences USD 9.3M 1.3M 2024-12
PTC Therapeutics USD 16.28M 5.44M 2024-12
Regeneron Pharmaceuticals USD 265.5M 299.9M 2025-03
Sarepta Therapeutics USD 132.3M 40.61M 2024-12
Ultragenyx Pharmaceutical USD 16.89M 4.13M 2024-12
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12



Ultragenyx Pharmaceutical Costo Del Venduto - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.